Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
55
days
Development of potent and selective ENPP1 inhibitors based on imidazo[1,2-a]pyrazine and pyrazine scaffolds for cancer immunotherapy
Authors
Zhiyue He; Yingying Zhang; Shiping Zhan; Tian Cao; Wanru Bai; Bozhi Zhou; Jie Yu; Huiying Zeng; Jingyi Zhou; Fuyun Tian; Xiaoyan Chen; Sulin Zhang; Mingyue Zheng; Xiaowei WuShow moreShow less
Affiliations
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China; School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, China; School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China; University of Chinese Academy of Sciences, Beijing, 100049, China; College of Pharmacy, Guangdong Pharmaceutical University, Guangdong, 510006, China; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China; School of Pharmaceutical Science and Technology, Hangzhou Institute of Advanced Study, UCAS, Hangzhou, 310024, ChinaShow moreShow less
43
days
Discovery and characterization of a sophoridine-derived TNIK inhibitor with antitumor activity in hepatocellular carcinoma
Authors
Yongquan Wei; Ziyi Wang; Die Sun; Zexu Xing; Haixia Yu; Lisheng WangShow moreShow less
Affiliations
School of Chemistry and Chemical Engineering, Guangxi University, Nanning, 530004, China; School of Chemical Engineering, Jilin Vocational College of Industry and Technology, Jilin, 132000, China; Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, 530004, ChinaShow moreShow less
155
days
Synthesis and biological evaluation of novel gemcitabine-dexamethasone hybrid as potent antitumor agents against esophageal cancer
Authors
Ruoxin Liu; Na Liu; Yimeng Wang; Jingyu Yang; Yuxin Chen; Xingjia Ma; Weijin Sheng; Kai Lv; Xiujun LiuShow moreShow less
Affiliations
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, ChinaShow moreShow less
45
days
Discovery of a novel anti-ischemic acute kidney injury candidate from pestaphilones, a new subtype of azaphilones derived from marine fungus
Authors
Jianglian She; Jian Cai; Chuanliang Wei; Xiaoqiang He; Rongxiang Qiu; Xin Qi; Xinlong Li; Tanwei Gu; Xi Zhang; Zhihao Zeng; Xinqi Chen; Yuanxin Tian; Wei Xu; Yonghong Liu; Xuefeng Zhou; Lan TangShow moreShow less
Affiliations
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China; State Key Laboratory of Tropical Oceanography, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, 510301, China; University of Chinese Academy of Sciences, Beijing, 100049, China; Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China; Guangxi Key Laboratory of Marine Drugs, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning, 530200, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days